CIBC Bancorp USA’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PGEN
PCM
BCM
IAM
CIBC Bancorp USA's PGEN Position: Q2 2026 in Review
CIBC Bancorp USA increased its Precigen (PGEN) stake by 66% in Q2 2026, buying an estimated $856K and bringing the position to 499,912 shares worth $2.85M. The position accounts for ﹤0.01% of the portfolio, ranked #882.
CIBC Bancorp USA first reported a position in PGEN in Q3 2025 and has held it in 3 quarters since. 197 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.
- CIBC Bancorp USA held 499,912 shares of Precigen worth $2.85M as of Q2 2026.
- CIBC Bancorp USA bought 197,924 Precigen shares in Q2 2026, an estimated $856K.
- Precigen made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #882 holding.
- CIBC Bancorp USA first reported a position in Precigen in Q3 2025 and has held it in 3 quarters since.
- 197 funds tracked by Wall St. Rank held Precigen as of Q2 2026.
Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.